S. Forgue

发表

Model-Based Drug Development: The Road to Quantitative Pharmacology

Vikram Sinha, Sophie Callies, Richard Peck, 2006, Journal of Pharmacokinetics and Pharmacodynamics.

In Vitro-in Vivo Correlations — Quo Vadis

P. Welling, S. Forgue, J. Cook, 1995 .

Population Dose-Response Model for Tadalafil in the Treatment of Male Erectile Dysfunction

I. Trocóniz, A. Staab, C. Tillmann, 2004, Pharmaceutical Research.

Gemcitabine in Patients With Solid Tumors and Renal Impairment: A Pharmacokinetic Phase I Study

T. le Chevalier, S. Delaloge, S. Forgue, 2004, American journal of clinical oncology.

Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.

M. Mitchell, R. Wrishko, A. Bedding, 2007, British journal of clinical pharmacology.

Tadalafil population pharmacokinetics in patients with erectile dysfunction

I. Trocóniz, A. Staab, C. Tillmann, 2007, European Journal of Clinical Pharmacology.

ffect of tadalafil on cytochrome P 450 A 4 – mediated clearance : Studies in vitro nd in vivo

J. Gillespie, S. Wrighton, M. Mitchell, 2004 .

Effects of Atorvastatin, an HMG‐CoA Reductase Inhibitor, on Hepatic Oxidative Metabolism of Antipyrine

A. Sedman, B. Yang, Bing‐Bing Yang, 1996, Journal of clinical pharmacology.

Confidence Interval Criteria for Assessment of Dose Proportionality

F. Vandenhende, K. Desante, N. Farid, 2004, Pharmaceutical Research.

Pharmacokinetic and Pharmacodynamic Comparisons of Twice Daily and Four Times Daily Formulations of Procainamide in Patients with Frequent Ventricular Premature Depolarization

A. Uprichard, B. Yang, S. Forgue, 1996, Journal of clinical pharmacology.

HE TURNOVER RATE OF TUBULIN IN RAT BRAIN

S. Forgue, J. Dahl, 1978 .

Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure

Stephen F. Lowry, Venkata Bandi, Alex Dmitrienko, 2003, Critical care medicine.

High-performance liquid chromatographic analysis of a novel carbapenem antibiotic in human plasma and urine.

K. Pittman, S. Forgue, R. Barbhaiya, 1987, Journal of chromatography.

Pharmacokinetics of cefepime in subjects with renal insufficiency

G. Matzke, D. Guay, K. Pittman, 1990, Clinical pharmacology and therapeutics.

High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine

K. Pittman, S. Forgue, W. Shyu, 1987, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

D. Weidler, K. Pittman, S. Forgue, 1992, Antimicrobial Agents and Chemotherapy.

Disposition of the cephalosporin cefepime in normal and renally impaired subjects.

G. Matzke, C. Halstenson, J. Opsahl, 1991, Drug metabolism and disposition: the biological fate of chemicals.

Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses

D. Weidler, K. Pittman, S. Forgue, 1990, Antimicrobial Agents and Chemotherapy.

N-oxidation of N-methylpyrrolidine released in vivo from cefepime.

S. Forgue, R. Barbhaiya, P. Kari, 1987, Drug metabolism and disposition: the biological fate of chemicals.

Tadalafil pharmacokinetics in healthy subjects.

M. Mitchell, R. Wrishko, A. Bedding, 2006, British journal of clinical pharmacology.

Identification of an arene oxide metabolite of 2,2',5-5'-tetrachlorobiphenyl by gas chromatography-mass spectroscopy.

S. Forgue, J. Allen, 1982, Chemico-biological interactions.

Pharmacokinetics of a 7‐Day 17β‐Estradiol Transdermal Delivery System: Effect of Application Site and Repeated Applications on Serum Concentrations of Estradiol and Estrone

A. Sedman, R. Boyd, Bing‐Bing Yang, 1996, Journal of clinical pharmacology.

Pharmacokinetics of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys

K. Pittman, S. Forgue, C. Gleason, 1987, Antimicrobial Agents and Chemotherapy.

Direct evidence that an arene oxide is a metabolic intermediate of 2,2',5,5'-tetrachlorobiphenyl.

B. Preston, S. Forgue, J. Allen, 1979, Biochemical and biophysical research communications.

Determination of tiodazosin concentrations in human plasma with a fluorescence high-performance liquid chromatographic method.

S. Forgue, R. D. Smyth, D. R. van Harken, 1985, Journal of chromatography.

RAT BRAIN TUBULIN: SUBUNIT HETEROGENEITY AND PHOSPHORYLATION

S. Forgue, J. Dahl, 1979, Journal of neurochemistry.

Safety, Tolerance, andPharmacokinetic Evaluation ofCefepime after Administration ofSingle Intravenous Doses

D. Weidler, K. Pittman, S. Forgue, 1990 .

Effect of Tadalafil on Cytochrome P450 3A4–mediated Clearance: Studies in Vitro and in Vivo

J. Gillespie, B. Ring, S. Wrighton, 2005, Clinical pharmacology and therapeutics.

Inhibition of tacrine oral clearance by cimetidine

A. Sedman, S. Forgue, T. Devries, 1996, Clinical pharmacology and therapeutics.